Neurocrine
$92.619876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$92.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.74 (-0.79%) As of 7:59 PM UTC today
Why Robinhood?
You can buy or sell Neurocrine and other stocks, options, and ETFs commission-free!
About NBIX
Neurocrine Biosciences, Inc. Common Stock, also called Neurocrine, is a neuroscience-focused, biopharmaceutical company.
CEO
Kevin Charles Gorman
Employees
845
Headquarters
San Diego, California
Founded
1992
Market Cap
8.95B
Price-Earnings Ratio
22.42
Dividend Yield
—
Average Volume
3.14M
High Today
$93.33
Low Today
$90.42
Open Price
$92.34
Volume
788.85K
52 Week High
$136.27
52 Week Low
$86.02
Analyst Ratings
65%
of 26 ratings
Buy
65%
Hold
35%
Sell
0%
NBIX Earnings
$0.00
$0.47
$0.95
$1.42
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, After Hours